NovoCure Ltd

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $82.9m $177.0m $248.1m $351.3m $494.4m $535.0m $537.8m $509.3m $605.2m $655.4m
Cost of Goods and Services Sold $39.9m $55.6m $80.0m $88.6m $106.5m $114.9m $114.9m $128.3m $137.2m $166.9m
Gross Profit $36.6m $121.4m $168.0m $262.7m $387.9m $420.2m $423.0m $381.1m $468.0m $488.5m
Operating Expenses $151.9m $160.7m $201.7m $263.6m $357.5m $464.5m $512.5m $613.9m $638.5m $642.3m
Operating Income (Loss) ($115.3m) ($39.3m) ($33.7m) ($914k) $30.4m ($44.3m) ($89.5m) ($232.9m) ($170.5m) ($153.8m)
Additional Financial Items
Capitalized Computer Software, Amortization $731k $1.2m $1.5m $1.7m $1.4m $1.1m $1.1m $1.3m $1.4m $1.5m
Foreign Currency Transaction Gain (Loss), before Tax $917k $699k ($3.2m) $3.3m ($161k) $227k ($1.3m)
Income (Loss) from Continuing Operations before Income Taxes, Domestic ($81.0m) ($77.7m) ($114.9m) ($87.9m) ($15.3m) $82.2m ($269.6m) ($281.7m) ($205.3m) ($205.4m)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($121.5m) ($48.5m) ($45.9m) ($8.8m) $18.1m ($52.1m) ($81.8m) ($191.7m) ($131.2m) ($136.2m)
Net Income (Loss) Attributable to Parent ($131.8m) ($61.7m) ($63.6m) ($7.2m) $19.8m ($58.4m) ($92.5m) ($207.0m) ($168.6m) ($136.2m)
Net Income (Loss) Available to Common Stockholders, Basic ($131.8m) ($61.7m) ($63.6m) ($7.2m) $19.8m ($58.4m) ($92.5m) ($207.0m) ($168.6m) ($136.2m)
Earnings Per Share, Basic $0.20 ($0.56) ($0.88) ($1.95) ($1.56) ($1.22)
Earnings Per Share, Diluted $0.18 ($0.56) ($0.88) ($1.95) ($1.56) ($1.22)
Weighted Average Number of Shares Outstanding, Basic 100.9m 103.4m 104.7m 106.4m 107.8m 111.5m
Weighted Average Number of Shares Outstanding, Diluted 108.9m 103.4m 104.7m 106.4m 107.8m 111.5m
Research and Development Expense $41.5m $38.1m $50.6m $79.0m $132.0m $201.3m $206.1m $223.1m $209.6m $224.5m
General and Administrative Expense $51.0m $59.1m $73.5m $87.9m $107.4m $126.1m $132.8m $164.1m $189.8m $177.7m
Current Income Tax Expense (Benefit) $10.4m $13.5m $17.3m ($1.7m) ($1.7m) $6.3m $10.7m $15.3m $37.5m ($23k)
Interest Expense $7.3m $11.7m $16.9m $14.6m $18.1m $8.8m $8.1m $4.9m $11.7m $22.2m
Interest Expense, Debt $5.9m $10.3m $13.5m $13.7m
Operating Lease, Expense $6.0m $7.3m $7.1m $8.2m $9.2m $12.0m
Restructuring Costs $6.2m $2.0m $0
Selling and Marketing Expense $59.4m $63.5m $77.7m $96.7m $118.0m $137.1m $173.7m $226.8m $239.1m $240.1m
Income Tax Expense (Benefit) $10.4m $13.2m $17.6m ($1.6m) ($1.7m) $6.3m $10.7m $15.3m $37.5m ($23k)
Interest Income (Expense), Nonoperating, Net $7.7m $41.1m $39.3m $17.6m